Clinical Trial Update: Paclitaxel Plus Radiation With Erlotinib to Treat Esophageal Squamous Carcinoma [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study evaluating paclitaxel plus radiation with erlotinib for esophageal squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• ERLOTINIB (Erlotinib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | Conditions: Esophageal Squamous Carcinoma | Phase 3 | Status: UNKNOWN